Advisory Services Network’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-999
Closed -$26.8K 3177
2026
Q1
$26.8K Buy
+999
New +$29.9K ﹤0.01% 3010
2025
Q4
Sell
-1,767
Closed -$54.2K 2807
2025
Q3
$54.2K Buy
+1,767
New +$43.1K ﹤0.01% 2417
2024
Q1
Sell
-1,118
Closed -$35.6K 2331
2023
Q4
$35.6K Buy
+1,118
New +$35.1K ﹤0.01% 2198
2023
Q2
Sell
-258
Closed -$9.74K 2314
2023
Q1
$9.74K Buy
258
+125
+94% +$4.8K ﹤0.01% 2882
2022
Q4
$5.64K Buy
+133
New +$5.48K ﹤0.01% 3081
2021
Q3
Sell
-55
Closed -$2K 2139
2021
Q2
$2K Buy
+55
New +$2.12K ﹤0.01% 3309
2021
Q1
Sell
-55
Closed -$2K 1953
2020
Q4
$2K Sell
55
-750
-93% -$28K ﹤0.01% 3002
2020
Q3
$29K Buy
+805
New +$29.1K ﹤0.01% 1884
2020
Q2
Sell
-283
Closed -$6K 1707
2020
Q1
$6K Sell
283
-125
-31% -$2.79K ﹤0.01% 2408
2019
Q4
$9K Buy
+408
New +$8.9K ﹤0.01% 2395

Other funds holding GMAB

Advisory Services Network's GMAB Position: Q2 2026 in Review

Advisory Services Network sold out of Genmab (GMAB) in Q2 2026, closing a stake of 999 shares — an estimated $26.8K sold.

Advisory Services Network first reported a position in GMAB in Q4 2019 and held it in 10 quarters. The position peaked at $54.2K in Q3 2025. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Advisory Services Network reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 999 Genmab shares in Q2 2026, an estimated $26.8K.
  • Advisory Services Network first reported a position in Genmab in Q4 2019 and held it in 10 quarters.
  • Advisory Services Network's Genmab position peaked at $54.2K in Q3 2025.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.